Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Journal of Magnetic Resonance Imaging : JMRI
|
March 2, 2013
Water-fat MRI for assessing changes in bone marrow composition due to radiation and chemotherapy in gynecologic cancer patients
Patrick J Bolan, Luke Arentsen, Thanasak Sueblinvong, et al.
Ecancermedicalscience
|
July 10, 2026
Management of epithelial ovarian cancer in sub-Saharan Africa: a survey of practicing physicians
Ya Haddy Sallah, Verna Vanderpuye, Rahel Ghebre, et al.
Gynecologic Oncology
|
August 3, 2010
Learning about ovarian cancer at the time of diagnosis: video versus usual care
Melissa A Geller, Levi S Downs, Patricia L Judson, et al.
Cancer Immunology, Immunotherapy : CII
|
September 8, 2010
Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers
Melissa A Geller, Sarah Cooley, Peter A Argenta, et al.
Preventive Medicine Reports
|
January 31, 2024
Integrating HPV self-collect into primary care to address cervical cancer screening disparities
Rebekah Pratt, Christina Bliss Barsness, John Lin, et al.
Gynecologic Oncology
|
November 27, 2016
The effect of photobiomodulation on chemotherapy-induced peripheral neuropathy: A randomized, sham-controlled clinical trial
Peter A Argenta, Karla V Ballman, Melissa A Geller, et al.
Contemporary Clinical Trials
|
November 19, 2024
Design of a pragmatic trial integrating human papillomavirus (HPV) self-sampling into primary care to reduce cervical cancer screening disparities in Somali American individuals: The Isbaar project
John Lin, Rachel L Winer, Christina Bliss Barsness, et al.
Gynecologic Oncology
|
January 18, 2011
A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancer
Melissa A Geller, Joseph J Ivy, Rahel Ghebre, et al.
Cancer
|
December 7, 2007
A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma
Levi S Downs, Patricia L Judson, Peter A Argenta, et al.
Oncotarget
|
April 29, 2016
USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment
Rachel Isaksson Vogel, Tanya Pulver, Wiebke Heilmann, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Journal of Magnetic Resonance Imaging : JMRI
|
March 2, 2013
Water-fat MRI for assessing changes in bone marrow composition due to radiation and chemotherapy in gynecologic cancer patients
Patrick J Bolan, Luke Arentsen, Thanasak Sueblinvong, et al.
Ecancermedicalscience
|
July 10, 2026
Management of epithelial ovarian cancer in sub-Saharan Africa: a survey of practicing physicians
Ya Haddy Sallah, Verna Vanderpuye, Rahel Ghebre, et al.
Gynecologic Oncology
|
August 3, 2010
Learning about ovarian cancer at the time of diagnosis: video versus usual care
Melissa A Geller, Levi S Downs, Patricia L Judson, et al.
Cancer Immunology, Immunotherapy : CII
|
September 8, 2010
Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers
Melissa A Geller, Sarah Cooley, Peter A Argenta, et al.
Preventive Medicine Reports
|
January 31, 2024
Integrating HPV self-collect into primary care to address cervical cancer screening disparities
Rebekah Pratt, Christina Bliss Barsness, John Lin, et al.
Gynecologic Oncology
|
November 27, 2016
The effect of photobiomodulation on chemotherapy-induced peripheral neuropathy: A randomized, sham-controlled clinical trial
Peter A Argenta, Karla V Ballman, Melissa A Geller, et al.
Contemporary Clinical Trials
|
November 19, 2024
Design of a pragmatic trial integrating human papillomavirus (HPV) self-sampling into primary care to reduce cervical cancer screening disparities in Somali American individuals: The Isbaar project
John Lin, Rachel L Winer, Christina Bliss Barsness, et al.
Gynecologic Oncology
|
January 18, 2011
A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial cancer
Melissa A Geller, Joseph J Ivy, Rahel Ghebre, et al.
Cancer
|
December 7, 2007
A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma
Levi S Downs, Patricia L Judson, Peter A Argenta, et al.
Oncotarget
|
April 29, 2016
USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment
Rachel Isaksson Vogel, Tanya Pulver, Wiebke Heilmann, et al.
Page
of 5